Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN13906399) titled 'Phase 1 trial HMR code: 25-006' on Sept. 29.
Study Type: Interventional
Study Design:
Safety and pharmacokinetics trial in up to 36 healthy women (Other)
Primary Sponsor: Medherant Limited
Condition:
Healthy volunteers
Other
Intervention:
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Recruitment Status: Recruiting
Phase: Phase I
Date of First Enrollment: 07/10/2025
Target Sample Size: 36
Countries of Recruitment:
England
United Ki...